2024-11-14T17:30:17+00:00 2023-12-31 346565596 ERNST & YOUNG US LLP 155 N WACKER DRIVE CHICAGO IL 60606 990 2023-01-01 131924236 MEMORIAL SLOAN-KETTERING CANCER CENTER MEMO 6462273092 1275 YORK AVENUE NEW YORK NY 100656007 Michael P Harrington EVP & CFO 4642272638 2024-11-14 true true Kristen Farr Capizzi P02176875 3128792000 2024-11-14 2023 2024-10-15 13:58:12Z SELWYN M VICKERS MD 1275 YORK AVENUE NEW YORK NY 100656007 1991911058 false 3475 X WWW.MSKCC.ORG X LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. 30 29 25365 370 13484538 0 142197000 211109934 1229087000 1273993000 545283000 215146000 -70522000 -29891934 1846045000 1670357000 0 0 0 0 785589238 815127600 0 0 79820612 692272762 692605113 1477862000 1507732713 368183000 162624287 7930219000 8540897000 4419687000 4125786000 3510532000 4415111000 MEMORIAL SLOAN-KETTERING CANCER CENTER IS DEDICATED TO THIS MISSION: LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST-EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. false false 1324320315 0 1208637000 SEE SCHEDULE O 30181627 0 4766000 SEE SCHEDULE O 12692025 0 0 MSKCC PAYS FEES TO CORNELL MEDICAL CENTER AND OTHER MEDICAL INSTITUTIONS FOR STAFF TO FURTHER THEIR SCIENTIFIC EDUCATION. IN ADDITION, THE CENTER HOSTS A NUMBER OF SYMPOSIUMS, SOME OF WHICH ARE OPEN TO THE PUBLIC. 1367193967 true true false true false false false false true true true false false true false false true false true true false false false true false false false false true true false false false false false false false false false false true false false false true true true true false false true 1379 0 true 25365 true true true false false false false true true false false false false true false X 30 29 true false false false false false false true true false false false true true true true true true true true true AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X KEVIN MALARKEY 6462272638 633 THIRD AVENUE NEW YORK NY 10017 SELWYN VICKERS MD BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE 50.0 0 X X 5489537 0 297622 ALAN SCHNITZER Board Member 2.0 0 X 0 0 0 ALEXANDER T ROBERTSON Board Member 2.0 0 X 0 0 0 ANTHONY B EVNIN Board Member 2.0 0 X 0 0 0 BENJAMIN W HEINEMAN JR Board Member 2.0 0 X 0 0 0 BRUCE C RATNER Board Member 2.0 0 X 0 0 0 CLIFTON S ROBBINS Board Member 2.0 0 X 0 0 0 DOUGLAS A WARNER III HONORARY CHAIR OF THE BOARD 5.0 0 X 0 0 0 ELLEN V FUTTER Board Member 2.0 0 X 0 0 0 HENRY A FERNANDEZ Board Member 2.0 0 X 0 0 0 IAN COOK VICE CHAIR OF THE BOARD 5.0 0 X 0 0 0 JAMES D ROBINSON III Board Member 2.0 0 X 0 0 0 JAMES G NIVEN Board Member 2.0 0 X 0 0 0 JAMIE C NICHOLLS Board Member 2.0 0 X 0 0 0 JOHN R STRANGFELD Board Member 2.0 0 X 0 0 0 JONATHAN N GRAYER Board Member 2.0 0 X 0 0 0 LOUIS V GERSTNER JR Board Member 2.0 0 X 0 0 0 MARGARET KEANE Board Member 2.0 0 X 0 0 0 MARIE-JOSEE KRAVIS VICE CHAIR OF THE BOARD 5.0 0 X 0 0 0 PETER A WEINBERG Board Member 2.0 0 X 0 0 0 PETER J SOLOMON Board Member 2.0 0 X 0 0 0 RICHARD BEATTIE Board Member 2.0 0 X 0 0 0 RICHARD N FOSTER Board Member (UNTIL 10/23) 2.0 0 X 0 0 0 ROGER W FERGUSON Board Member 2.0 0 X 0 0 0 SCOTT M STUART CHAIR OF THE BOARD 5.0 0 X 0 0 0 STANLEY F DRUCKENMILLER Board Member 2.0 0 X 0 0 0 STEPHEN C SHERRILL Board Member 2.0 0 X 0 0 0 STEPHEN FRIEDMAN Board Member 2.0 0 X 0 0 0 VIRGINIA M ROMETTY Board Member 2.0 0 X 0 0 0 WILLIAM E FORD Board Member 2.0 0 X 0 0 0 WILLIAM HELMAN Board Member 2.0 0 X 0 0 0 AMADOR CENTENO SVP OF FACILITIES MANAGEMENT & REAL ESTATE DEVELOPMENT (UNTIL 10/23) 50.0 0 X 1063117 0 30628 ANAEZE OFFODILE MD EVP, CHIEF STRATEGY OFFICER (EFF 5/23) 50.0 0 X 544669 0 35845 CAROLYN LEVINE ESQ VP, DEPUTY GENERAL COUNSEL & CORPORATE SECRETARY 50.0 0 X 565599 0 65538 DEBRA BERNS SVP & CHIEF RISK OFFICER 50.0 0 X 1136118 0 46654 ERIN MCDONOUGH EVP, CHIEF MARKETING & COMMUNICATION OFFICER 50.0 0 X 985689 0 45086 JASON KLEIN SVP & CHIEF INVESTMENT OFFICER 50.0 0 X 3498969 0 82476 JORGE LOPEZ EVP & GENERAL COUNSEL 50.0 0 X 1508282 0 82296 KATHRYN MARTIN CHIEF OPERATING OFFICER (UNTIL 3/23) 50.0 0 X 4698854 0 63637 KENNETH MANOTTI SVP, CHIEF DEVELOPMENT OFFICER 50.0 0 X 1921418 0 70484 KERRY BESSEY SR VP/CHIEF HUMAN RESOURCES OFCR (UNTIL 3/23) 50.0 0 X 1702273 0 79897 LAKISHA MACK EVP, CHIEF ADMINISTRATIVE OFFICER (EFF 3/23) 50.0 0 X 616975 0 57205 MARK SVENNINGSON VP, FINANCE (UNTIL 2/23) 50.0 0 X 1766755 0 15004 MICHAEL HARRINGTON EVP & CHIEF FINANCIAL OFFICER 50.0 0 X 2334269 0 64501 REMY EVARD EVP, CHIEF DIGITAL OFFICER 50.0 0 X 1589476 0 71898 TOMYA WATT EVP, INTERIM CHIEF HUMAN RESOURCES OFFICER (EFF 3/23) 50.0 0 X 898519 0 71031 GREGORY RASKIN VP TECHNOLOGY DEVELOPMENT 50.0 0 X 1086845 0 78944 NIRSCHL NOVISI DIRECTOR INVESTMENTS 50.0 0 X 1083540 0 81171 STEVEN KAEL DIRECTOR INVESTMENTS 50.0 0 X 1125083 0 70416 THOMAS BARBER Deputy Physician in Chief 50.0 0 X 1056958 0 56179 WENDY PERCHICK SVP STRATEGIC PLANNING 50.0 0 X 1502475 0 19243 CRAIG THOMPSON MD FORMER PRESIDENT & CEO 0.0 50.0 X 0 2021713 70070 ROXANNE TAYLOR Former Officer 0.0 0 X 1077404 0 0 37252824 2021713 1555825 2349 true true false CANNON DESIGN ARCHITECTURE 300 e 42nd st New York NY 10017 architecture 23119690 JGN CONSTRUCTION CORP 66-40 69TH ST MIDDLE VILLAGE NY 11379 CONSTRUCTION 21982458 LEND LEASE US CONSTRUCTION 200 PARK AVE New Yotk NY 10166 CONSTRUCTION 14413816 VARIAN MEDICAL SYSTEMS INC 3120 HANSEN WAY M/S G100 PALO ALTO CA 943041038 CONSTRUCTION 12409706 GE PRECISION HEALTHCARE LLC 500 W MONROE ST CHICAGO IL 60661 CONSTRUCTION 8759609 209 3535934 1109000 206465000 6461350 211109934 SERVICES PROVIDED SEE NOTE A & ATTACH.1 900099 1269227000 1269227000 CAFETERIA 721000 4766000 4766000 0 0 0 0 1273993000 68631000 13484538 55146462 0 0 467297086 320782086 146515000 0 146515000 146515000 121365 3535934 771972 -650607 -650607 INTERCORPORATE CORRECTION PY CONTRIB 900099 -60590000 -60590000 FICA CREDIT & HEALTH WORK BONUS 900099 10491000 10491000 VENDOR DISCOUNT 900099 2656000 2656000 18201673 0 0 18201673 -29241327 1670357000 1213403000 13484538 232359528 0 0 40830363 33995897 4803114 2031352 581915146 536482174 11251456 34181516 42379524 39323997 1106660 1948867 110833841 101551410 2214769 7067662 39168726 36155348 1015842 1997536 14200477 11715574 2463960 20943 1596974 1580410 15934 630 901671 901671 10018167 10018167 105833394 92010481 7415424 6407489 41618441 39956121 1662320 162445143 129918345 9677375 22849423 123069320 112986833 8836357 1246130 36633240 35887402 642622 103216 2540465 2205466 154641 180358 5447333 5127059 37173 283101 35991435 35991435 120571540 120210060 106770 254710 3185915 2999033 26142 160740 NET REQUISITIONED SERVICES 21155669 20360958 794711 MED/SURG SUPPLIES 7536525 7405167 131358 PHARMACEUTICALS 429900 429126 774 UBIT EXPENSE 4885 4885 -575381 0 0 -575381 1507732713 1367193967 60718134 79820612 X 12952793 3633255 9319538 269934000 553103000 1011324000 881428000 155736000 150679000 93819000 0 0 0 0 76449000 85809000 2142000 2484000 579222000 527751000 2044533000 953808000 1019335000 1090725000 2968403000 3309131000 1847674000 1845968000 0 0 0 7930219000 8540897000 589307000 802838000 1922836000 1851961000 0 0 1350000000 1350000000 557544000 120987000 4419687000 4125786000 X 3155396000 4072476000 355136000 342635000 3510532000 4415111000 7930219000 8540897000 X 162624287 347214000 394740713 X false true X true true true X 31560247 42290773 257200000 52163000 150519934 533733954 0 0 31560247 42290773 257200000 52163000 150519934 533733954 113964508 419769447 70401294 40351435 2993504 73534686 55146462 242427381 0 0 0 0 0 0 0 776161335 5382635234 0.5408 0.4931 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 0 0 0 0 0 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 0 543822 901671 543822 901671 1507188891 1507188891 1507732713 1508090562 1000000 1000000 250000 250000 0 0 0 0 false 1000000 1000000 1000000 1000000 4000000 6000000 675588 540244 829671 901671 2947174 250000 250000 250000 250000 1000000 1500000 0 0 Schedule C, Part II-A, Line 1c, Column (b) TOTAL LOBBYING EXPENDITURES REMAINING LOBBYING EXPENDITURES OF $357,849 ARE FROM: MEMORIAL HOSPITAL FOR CANCER AND ALLIED DIESES 1275 YORK AVENUE NEW YORK, N.Y. 10065 13-1624082 406391000 3011000 57000 409459000 405858000 1118000 -585000 406391000 397079000 7845000 934000 405858000 396451000 636000 -8000 397079000 385622000 10435000 394000 396451000 0.47 0.53 false false 34802000 34802000 796442000 122319000 674123000 16804000 11826000 4978000 1073990000 808434000 265556000 122495000 11229000 111266000 1090725000 PRIVATE EQUITY & VENTURE CAPITAL 1845968000 F 1845968000 captive insurance loan agreement 71799000 employee benefit funds 12719000 deferred gift annuity 11955000 aro liability 2913000 other 238000 operating leases 21363000 120987000 1993897000 347214000 772000 347986000 1645911000 24446000 0 24446000 1670357000 1484058713 772000 772000 1483286713 24446000 0 24446000 1507732713 Schedule D, Part V, Line 4 Intended uses of endowment funds PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990 SPECIAL EVENTS EXPENSES OFFSETTING REVENUE - 772000 Schedule D, Part XII, Line 2(d) Other expenses in audited financial statements not in form 990 special events expense offset revenue - 772000 Middle East and North Africa 0 2 Program Services ADMIN SUPPORT 7440 Europe (Including Iceland and Greenland) 0 6 Program Services ADMIN SUPPORT 41480 Central America and the Caribbean 0 1 Program Services ADMIN SUPPORT 992 East Asia and the Pacific 0 7 Program Services ADMIN SUPPORT 10976 North America (Canada & Mexico only) 0 2 Program Services ADMIN SUPPORT 8211 Sub-Saharan Africa 0 1 Program Services ADMIN SUPPORT 3093 Central America and the Caribbean 0 0 Investments 2182988751 Sub-Saharan Africa 0 0 Investments 46293175 Europe (Including Iceland and Greenland) 0 0 Investments 27961877 0 19 0 0 0 19 2257315995 0 2257315995 true true true true false Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements CENTRAL AMERICA AND THE CARIBBEAN-Cash,Other:FMV; EAST ASIA AND THE PACIFIC-Cash; EUROPE (INCLUDING ICELAND AND GREENLAND)-Cash,Other:FMV; MIDDLE EAST AND NORTH AFRICA-Cash; NORTH AMERICA (CANADA & MEXICO ONLY)-Cash; SUB-SAHARAN AFRICA-Cash,Other:FMV SPRING BALL 2021781 1982281 39500 119163 11000 171816 FALL PARTY 621874 613034 8840 121383 15600 59388 2 1012644 939619 73025 141144 61950 70528 3656299 3534934 121365 381690 88550 301732 771972 -650607 X X true true X X X X X true false false false false false false true true true SELWYN VICKERS MD BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE 2987929 0 2458333 0 43275 0 26400 0 271222 0 5787159 0 0 0 ROXANNE TAYLOR Former Officer 0 0 299279 0 778125 0 0 0 0 0 1077404 0 0 0 CRAIG THOMPSON MD FORMER PRESIDENT & CEO 0 702433 0 1138583 0 180697 0 26400 0 43670 0 2091783 0 0 DEBRA BERNS SVP & CHIEF RISK OFFICER 757092 0 373500 0 5526 0 26400 0 20254 0 1182772 0 0 0 KERRY BESSEY SR VP/CHIEF HUMAN RESOURCES OFCR (UNTIL 3/23) 730628 0 945368 0 26277 0 26400 0 53497 0 1782170 0 0 0 AMADOR CENTENO SVP OF FACILITIES MANAGEMENT & REAL ESTATE DEVELOPMENT (UNTIL 10/23) 651000 0 217500 0 194617 0 26400 0 4228 0 1093745 0 0 0 REMY EVARD EVP, CHIEF DIGITAL OFFICER 810042 0 745000 0 34434 0 26400 0 45498 0 1661374 0 0 0 MICHAEL HARRINGTON EVP & CHIEF FINANCIAL OFFICER 1487308 0 822841 0 24120 0 26400 0 38101 0 2398770 0 0 0 JASON KLEIN SVP & CHIEF INVESTMENT OFFICER 1133496 0 2225250 0 140223 0 26400 0 56076 0 3581445 0 0 0 CAROLYN LEVINE ESQ VP, DEPUTY GENERAL COUNSEL & CORPORATE SECRETARY 463342 0 92458 0 9799 0 26400 0 39138 0 631137 0 0 0 JORGE LOPEZ EVP & GENERAL COUNSEL 986585 0 499614 0 22083 0 26400 0 55896 0 1590578 0 0 0 LAKISHA MACK EVP, CHIEF ADMINISTRATIVE OFFICER (EFF 3/23) 565561 0 50000 0 1414 0 26400 0 30805 0 674180 0 0 0 KENNETH MANOTTI SVP, CHIEF DEVELOPMENT OFFICER 922339 0 967794 0 31285 0 26400 0 44084 0 1991902 0 0 0 KATHRYN MARTIN CHIEF OPERATING OFFICER (UNTIL 3/23) 531356 0 3043618 0 1123880 0 26400 0 37237 0 4762491 0 0 0 ERIN MCDONOUGH EVP, CHIEF MARKETING & COMMUNICATION OFFICER 769518 0 210310 0 5861 0 26400 0 18686 0 1030775 0 0 0 ANAEZE OFFODILE MD EVP, CHIEF STRATEGY OFFICER (EFF 5/23) 468838 0 75000 0 831 0 26400 0 9445 0 580514 0 0 0 MARK SVENNINGSON VP, FINANCE (UNTIL 2/23) 163792 0 1600000 0 2963 0 8939 0 6065 0 1781759 0 0 0 TOMYA WATT EVP, INTERIM CHIEF HUMAN RESOURCES OFFICER (EFF 3/23) 635327 0 258419 0 4773 0 26400 0 44631 0 969550 0 0 0 THOMAS BARBER Deputy Physician in Chief 95751 0 150000 0 811207 0 20839 0 35340 0 1113137 0 0 0 STEVEN KAEL DIRECTOR INVESTMENTS 969701 0 154500 0 882 0 26400 0 44016 0 1195499 0 0 0 NIRSCHL NOVISI DIRECTOR INVESTMENTS 505417 0 578123 0 0 0 26400 0 54771 0 1164711 0 0 0 WENDY PERCHICK SVP STRATEGIC PLANNING 400977 0 400000 0 701498 0 2380 0 16863 0 1521718 0 0 0 GREGORY RASKIN VP TECHNOLOGY DEVELOPMENT 650254 0 294600 0 141991 0 26400 0 52544 0 1165789 0 0 0 Schedule J, Part I, Line 1a First-class or charter travel BUSINESS OR FIRST-CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN SIX CONTINUOUS HOURS FOR ANY EMPLOYEE NOT FUNDED BY FEDERAL GRANTS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATION. THE DUTIES TO BE PERFORMED BY OUR PRESIDENT REQUIRE HIM TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING HIS OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. Schedule J, Part I, Line 4a Severance or change-of-control payment INCLUDED IN FORM 990 IS SEVERANCE PAY FOR: KATHRYN MARTIN $1,117,022 ROXANNE TAYLOR $778,125. THOMAS BARBER $754,182. WENDY PERCHICK $700,543. FREDRICK GROVES $591,588. AMADOR CENTENO $153,365. MARGARET BURKE $132,180 Schedule J, Part I, Line 7 Non-fixed payments INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF PRE-DETERMINED GOALS RELATING TO QUALITY OF CARE, PATIENT SAFETY, OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE. THE COMPENSATION COMMITTEE OF THE BOARD AUTHORIZES ALL EXECUTIVE BONUSES AND INCENTIVE PLANS ON AN ANNUAL BASIS. IN ADDITION, AS WELL AS AN OVERALL AUTHORIZATION AND APPROVAL FOR KEY EMPLOYEES AND OTHER MANAGEMENT INCLUDING PROFESSIONAL AND OTHER STAFF BY SETTING THE BONUS POOL IN CONJUNCTION WITH THE INPUT FROM HUMAN RESOURCES. STAFF BONUSES ARE IMPACTED BY ANNUAL MERIT REVIEW PROCESS. Schedule J, Part I, Line 8 Payments on contract that is subject to the initial contract exception AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT. Schedule J, Part II Craig Thompson, MD was the President & CEO until September 2022. Since then, he became a Research Member of Sloan Kettering Institute for Cancer Research. His compensation includes a bonus earned in 2022 but paid in 2023. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2016-04-28 110000000 2016 SERIES BONDS WERE USED TO CONSTRUCT/RENOVATE AND UPGRADE AND EQUIP VARIOUS FACILITIES false false false B NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY 222045817 000000000 2016-09-09 145000000 2016 SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP VARIOUS FACILITIES. false false false C DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2017-12-20 335567386 2017 SERIES BONDS WERE USED TO CURRENT REFUND THE 2015 SERIES BONDS & CONSTRUCT VARIOUS FACILITIES false false false D DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 64990GVG4 2019-11-01 342248699 2019 SERIES BONDS WERE USED TO REIMBURSE EXPENDITURES INCURRED TO CONSTRUCT A PATIENT CARE FACILITY. false false false A 61120651 110239999 155282 110009717 75000 2017 false false true true B 90625000 145000000 72861 144627139 300000 2018 false false true true C 14320000 339194534 2262236 245499309 91432989 2019 true false true true D 342248699 2248699 340000000 2019 false false true true A false false false true false 0.0 false false true B false false false true false 0.0 false false true C false false false true false 0.0 false false true D false false false true false 0.0 false false true A false false false true false false false false true B false false false true false false false false true C false false false true false false false false true D false true false false false false false false true A true B true C true D true Schedule K, Part II Line 3 04/28/2016, 12/20/2017, 06/28/2022 and 08/01/2022 BOND ISSUES: TOTAL PROCEEDS OF THE ISSUE DOES NOT EQUAL ISSUE PRICE DUE TO INVESTMENT EARNINGS EARNED DURING THE PROJECT PERIOD. Schedule K, Part IV, Line 2c COLUMN A Issuer name: DORMITORY AUTHORITY OF THE STATE OF NEW YORK The calculation for computing no rebate due was performed on 05/19/2023 Schedule K, Part IV, Line 2c COLUMN B Issuer name: NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY The calculation for computing no rebate due was performed on 07/06/2022 Schedule K, Part IV, Line 2c COLUMN C Issuer name: DORMITORY AUTHORITY OF THE STATE OF NEW YORK The calculation for computing no rebate due was performed on 03/17/2023 A DOMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 65000BPS1 2022-06-28 199996589 2022 SERIES #1 BONDS WERE USED TO RENOVATE VARIOUS LOCATIONS - HOSPITAL AND OUTPATIENT FACILITIES A false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2022-08-01 100000000 2022 SERIES #2 BONDS WERE USED TO RENOVATE NON-PATIENT SPACE. false false false A 200507663 1220622 199162041 125000 2022 false false true true B 104083394 227400 57416988 15000 46424006 false false false true A false false false true false 0.0 false false true B false false false true false 0.0 false false true A false true false false false false false false true B false true false false false false false false true A true B true X 227 6461350 Market value 0 false true true Schedule M, Part I, Line 32b Third parties used to solicit, process, or sell noncash contributions PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER. Schedule M, Part I Explanations of reporting method for number of contributions Securities - Publicly traded - number of contributions Form 990, Part III, Line 4a Program Services MEMORIAL SLOAN-KETTERING CANCER CENTER PROVIDES THE FOLLOWING SERVICES TO ITS AFFILIATED ORGANIZATIONS: FINANCIAL ADMINISTRATION, EXECUTIVE MANAGEMENT, HUMAN RESOURCES, FACILITY MANAGEMENT, GENERAL AND ENVIRONMENTAL SERVICES, PROCUREMENT, PUBLIC AFFAIRS, RESEARCH TECHNOLOGY MANAGEMENT, CORPORATE COMPLIANCE, INFORMATION SYSTEMS AND TECHNOLOGY, AND INVESTMENT MANAGEMENT. IN ADDITION, CERTAIN SERVICES ARE PROVIDED ON A REQUISITION BASIS INCLUDING FOOD AND DIETARY SERVICES, FACILITIES MANAGEMENT (LOCKSMITH, ELECTRICIAN, PLUMBING, PAINTING AND CARPENTRY, ETC.) MEDICAL LIBRARY, CONFERENCE PLANNING, OCCUPANCY OF LEASED SPACE, TRANSPORTATION, IMMIGRATION SERVICES, MEDICAL ILLUSTRATION, MOTION MEDIA, SECURITY SERVICES SUCH AS INSTALLING ANTI-THEFT DEVICES AND MAILROOM SERVICES. Form 990, Part III, Line 4a Program Services CAFETERIA: THE CENTER OPERATES A CAFETERIA IN THE MAIN BUILDING COMPLEX WHERE VISITORS AND PATIENTS CAN PURCHASE MEALS AND SNACKS. SOCIETY OF MSKCC: THE SOCIETY OF MEMORIAL SLOAN-KETTERING CANCER CENTER, FOUNDED IN 1946, IS A VOLUNTEER ORGANIZATION DEDICATED TO PROMOTING THE WELL-BEING OF PATIENTS, SUPPORTING CANCER RESEARCH AND PROVIDING PUBLIC EDUCATION ON THE PREVENTION, EARLY DETECTION AND TREATMENT OF CANCER. PROSTATE CANCER CLINICAL TRIALS CONSORTIUM, LLC. (PCCTC): THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM (PCCTC) WAS INITIATED IN 2005 BY THE PROSTATE CANCER FOUNDATION (PCF) AND THE U.S. DEPARTMENT OF DEFENSE (DOD) PROSTATE CANCER RESEARCH PROGRAM (PCRP). ESTABLISHED AS AN INDEPENDENT ENTITY IN 2014, THE PCCTC, LLC IS NOW THE NATION'S PREMIER MULTICENTER CLINICAL RESEARCH ORGANIZATION SPECIALIZING IN CUTTING-EDGE PROSTATE CANCER RESEARCH. MSK IS THE SINGLE MEMBER OF THE PCCTC, WHO HAS ELECTED TO BE TREATED AS A DISREGARDED ENTITY OF MSK FOR TAX PURPOSES. THE COSTS SHOWN HERE FOR THE ABOVE PROGRAMS, ARE EXCLUSIVE OF FUNDRAISING ACTIVITIES, WHICH ARE REPORTED IN PART IX, COLUMN D. EXPENSE CAFETERIA $ 5,423,714 SOCIETY $ 3,906,827 PCCTC $17,427,773 TOTAL $26,758,314 REVENUE CAFETERIA $ 4,441,000 SOCIETY $ 0 PCCTC $18,978,000 TOTAL $23,419,000 Form 990, Part VI, Line 2 Family/business relationships amongst interested persons DIRECTORS ELLEN V. FUTTER AND PETER J. SOLOMON - Business relationship, DIRECTORS ELLEN V. FUTTER AND RICHARD I. BEATTIE - Business relationship Form 990, Part VI, Line 11b Review of form 990 by governing body PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE SENIOR VICE PRESIDENT OF FINANCE AND THE CHIEF FINANCIAL OFFICER. IN ADDITION, FORM 990 IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. Form 990, Part VI, Line 12c Conflict of interest policy IN 2023, MSK'S CONFLICT OF INTEREST (COI) PROGRAM WAS IMPLEMENTED THROUGH THREE COMPREHENSIVE POLICIES FOR MEMORIAL SLOAN KETTERING CANCER CENTER, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES AND SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, WHICH ARE OUTLINED BELOW: 1. CONFLICT OF INTEREST AND COMMITMENT POLICY (THE "INDIVIDUAL COI POLICY"). A. THE INDIVIDUAL COI POLICY APPLIED TO: (I) PHYSICIANS AND SCIENTISTS WITH ACADEMIC APPOINTMENTS AT ANY LEVEL; (II) ANY CLINICAL PROVIDER WHO COULD INDEPENDENTLY WRITE ORDERS OR PRESCRIPTIONS; (III) INDIVIDUALS WHOSE ROLES INCLUDED THE DESIGN, CONDUCT OR REPORTING OF RESEARCH AND/OR WERE ENGAGED IN HUMAN SUBJECT RESEARCH; (IV) ADMINISTRATIVE EMPLOYEES WITH INDEPENDENT AUTHORITY TO MAKE PURCHASING DECISIONS OR WHO WERE OTHERWISE ABLE TO BIND, NEGOTIATE ON BEHALF, OR EXECUTE AGREEMENTS ON BEHALF OF, MSK; AND (V) INDIVIDUALS THAT SERVED ON MSK INSTITUTIONAL COMMITTEES WITH RESPONSIBILITY FOR OVERSIGHT OF RESEARCH, FORMULARY, OR PURCHASING DECISIONS. B. MSK'S COMPLIANCE COI OFFICE ("COMPLIANCE") AND THE INSTITUTIONAL CONFLICT OF INTEREST COMMITTEE (THE "MSK COI COMMITTEE") WERE RESPONSIBLE FOR THE DMINISTRATION OF THIS POLICY, UNDER THE OVERSIGHT OF THE COMMITTEE OF THE BOARD (THE "BOARD COI COMMITTEE") DEDICATED EXCLUSIVELY TO DISCHARGING THE BOARD'S RESPONSIBILITY AND AUTHORITY OVER MSK'S CONFLICTS OF INTEREST PROGRAM. C. UPON BECOMING COVERED BY THE INDIVIDUAL COI POLICY, ANNUALLY THEREAFTER AND/OR AS NEW SIGNIFICANT INTERESTS AROSE, AN INDIVIDUAL WAS REQUIRED TO DISCLOSE FINANCIAL INTERESTS AND EXTERNAL RELATIONSHIPS AND ACTIVITIES ("INTERESTS"), WHETHER PAID OR UNPAID, THAT REASONABLY APPEARED TO BE RELATED TO THE INDIVIDUAL'S INSTITUTIONAL RESPONSIBILITIES. COVERED PERSONS WERE REQUIRED TO DISCLOSE INTERESTS FOR THEMSELVES AND IMMEDIATE FAMILY MEMBERS. D. DEPENDING ON THE CIRCUMSTANCES AND BASED ON ESTABLISHED CRITERIA, DISCLOSED INTERESTS WERE REVIEWED BY COMPLIANCE, THE MSK COI COMMITTEE, MSK COI COMMITTEE DESIGNEE(S), AND/OR THE BOARD COI COMMITTEE TO DETERMINE WHETHER AN INDIVIDUAL CONFLICT OF INTEREST EXISTED OR PRESENTED THE PERCEPTION THEREOF (I.E. WHETHER AN INDIVIDUAL FINANCIAL INTEREST COULD DIRECTLY AND SIGNIFICANTLY IMPACT AN INDIVIDUAL'S INSTITUTIONAL RESPONSIBILITIES, OR AN INDIVIDUAL'S INTEREST COULD BE DIRECTLY AND SIGNIFICANTLY IMPACTED BY THEIR INSTITUTIONAL RESPONSIBILITIES). E. THE POLICY REQUIRED ANY INDIVIDUAL CONFLICT OF INTEREST TO BE MANAGED, REDUCED OR ELIMINATED. WHEN A CONFLICT OF INTEREST DETERMINATION WAS MADE, THE MSK COI COMMITTEE, THE MSK COI COMMITTEE DESIGNEE(S), OR THE BOARD COI COMMITTEE, AS APPLICABLE, DETERMINED HOW TO ADDRESS IT. FOR THOSE CONFLICTS DEEMED MANAGEABLE, MANAGEMENT STRATEGIES IMPLEMENTED INCLUDED DISCLOSURE OF THE INTEREST IN RELEVANT PUBLICATIONS, PRESENTATIONS, CONSENT FORMS, AND EDUCATIONAL MATERIALS; RECUSAL AND/OR OTHER LIMITATION ON ROLE; INDEPENDENT OVERSIGHT BY A DISINTERESTED SENIOR PERSONNEL MEMBER OR COMMITTEE; AND TEMPORARY OR PERMANENT REDUCTION, DIVESTITURE, RELINQUISHMENT, OR TERMINATION OF AN INDIVIDUAL'S INTEREST. 2. INSTITUTIONAL CONFLICT OF INTEREST POLICY (THE "INSTITUTIONAL COI POLICY"). A. THE INSTITUTIONAL COI POLICY APPLIED TO FINANCIAL INTERESTS AND RELATIONSHIPS ("INTERESTS") HELD BY MSK AS AN INSTITUTION, AS WELL AS THOSE FINANCIAL INTERESTS AND RELATIONSHIPS ("INTERESTS") HELD BY SENIOR EXECUTIVE OFFICERS DEEMED "INSTITUTIONAL OFFICIALS, THEIR IMMEDIATE FAMILY MEMBERS. B. INSTITUTIONAL INTERESTS HELD BY MSK WERE MADE AVAILABLE TO COMPLIANCE THROUGH REGULAR REPORTS FROM AND ONGOING ENGAGEMENT WITH RELEVANT MSK DEPARTMENTS. INSTITUTIONAL INTERESTS HELD BY INSTITUTIONAL OFFICIALS WERE DISCLOSED THROUGH THE PROCESS DESCRIBED ABOVE IN THE INDIVIDUAL COI POLICY, AS WELL AS THE PROCESS DESCRIBED BELOW IN THE BOARD COI POLICY. C. THE MSK COI COMMITTEE OR MSK COI COMMITTEE DESIGNEE(S) WERE RESPONSIBLE FOR DETERMINING WHETHER AN INSTITUTIONAL CONFLICT OF INTEREST EXISTED; I.E. WHETHER THE INSTITUTIONAL INTEREST HELD BY MSK OR AN INSTITUTIONAL OFFICIAL (OR THEIR IMMEDIATE FAMILY MEMBERS) COULD, OR COULD REASONABLY BE PERCEIVED TO, DIRECTLY AND SIGNIFICANTLY AFFECT THE DESIGN, CONDUCT, REPORTING, REVIEW, OR OVERSIGHT OF MSK RESEARCH OR THE OUTCOME OF AN MSK ACTIVITY OR DECISION. D. THE POLICY REQUIRED ANY INSTITUTIONAL CONFLICT OF INTEREST TO BE MANAGED, REDUCED OR ELIMINATED. WHEN AN INSTITUTIONAL CONFLICT OF INTEREST DETERMINATION WAS MADE, THE MSK COI COMMITTEE AND/OR THE MSK COI COMMITTEE DESIGNEE(S) DETERMINED HOW TO ADDRESS IT. FOR THOSE CONFLICTS DEEMED MANAGEABLE, MANAGEMENT STRATEGIES IMPLEMENTED INCLUDED RECUSAL OF THE APPLICABLE INSTITUTIONAL OFFICIAL FROM DECISION-MAKING REGARDING THE ARRANGEMENT AND DISCLOSURE TO RELEVANT PERSONNEL; DISCLOSURE OF THE INTEREST IN RELEVANT PUBLICATIONS, PRESENTATIONS, CONSENT FORMS, AND EDUCATIONAL MATERIALS; INDEPENDENT OVERSIGHT BY A DISINTERESTED SENIOR PERSONNEL MEMBER OR COMMITTEE; AND TEMPORARY OR PERMANENT REDUCTION, DIVESTITURE, RELINQUISHMENT, OR TERMINATION OF MSK'S OR AN INSTITUTIONAL OFFICIAL'S INSTITUTIONAL INTEREST. 3. BOARDS OF GOVERNING TRUSTEES CONFLICT OF INTEREST POLICY (THE "BOARD COI POLICY"). A. THE BOARD COI POLICY APPLIED TO BOARD MEMBERS, OFFICERS, AND OTHER MSK SENIOR LEADERSHIP. INDIVIDUALS COVERED BY THE BOARD COI POLICY WERE REQUIRED TO DISCLOSE FINANCIAL INTERESTS AND RELATIONSHIPS, AS DEFINED BY THE POLICY, ANNUALLY AND ON AN ONGOING BASIS. OTHER ENTITIES IN THE SAME TAX-EXEMPT GROUP HAD OVERLAPPING OFFICERS AND BOARD MEMBERS AS DESCRIBED IN SCHEDULE O; SUCH PERSONS REPORTED FINANCIAL INTERESTS THROUGH THIS OR RELATED PROCESSES. B. THE BOARD COI COMMITTEE WAS RESPONSIBLE FOR DETERMINING WHETHER ANY INTEREST DISCLOSED UNDER THE BOARD COI POLICY GAVE RISE TO A CONFLICT OF INTEREST. THE POLICY REQUIRED THAT THE MEMBERS OF THE BOARD COI COMMITTEE VOTE, WITHOUT THE INDIVIDUAL WITH THE POTENTIAL CONFLICT PRESENT, TO DETERMINE WHETHER A CONFLICT OF INTEREST EXISTED. ALL MEMBERS PARTICIPATING IN THE VOTE WERE REQUIRED TO BE DISINTERESTED WITH RESPECT TO THE TRANSACTION, ARRANGEMENT, OR RELATIONSHIP. C. THE COVERED INDIVIDUAL WITH THE CONFLICT OF INTEREST COULD MAKE A PRESENTATION TO THE BOARD COI COMMITTEE, BUT COULD NOT PARTICIPATE IN OR INFLUENCE THE DISCUSSION OF, OR VOTE ON, THE PROPOSED TRANSACTION, ARRANGEMENT, OR RELATIONSHIP. THE EXISTENCE AND RESOLUTION OF ANY CONFLICT OF INTEREST, ALONG WITH ASSOCIATED DETERMINATIONS MADE AND VOTES TAKEN, WERE REQUIRED TO BE DOCUMENTED IN WRITING. D. FOR ANY TRANSACTION, ARRANGEMENT, OR RELATIONSHIP THAT INVOLVED A CONFLICT OF INTEREST, A CONFLICT MANAGEMENT PLAN COULD BE IMPLEMENTED IF DOING SO WAS IN THE BEST INTERESTS OF MSK. MANAGEMENT PLANS COULD REQUIRE DISCLOSURE, RECUSAL OR OTHER LIMITATION OF ROLE, INDEPENDENT OVERSIGHT AND CONFIDENTIALITY. Form 990, Part VI, Line 15a Process to establish compensation of top management official MEMORIAL SLOAN-KETTERING CANCER CENTER IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE BOARD OF TRUSTEES AND GOVERNING TRUSTEES HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARD TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC'S, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS MARCH 2022, WHICH SET THE COMPENSATION FOR THE PERIOD APRIL 2022 TO MARCH 2023. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. ON AN ANNUAL BASIS, THE COMMITTEE PROVIDES THE FULL BOARD WITH AN OVERVIEW OF ITS DETERMINATIONS AND PROCESS. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS' GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX-EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. Form 990, Part VI, Line 19 Required documents available to the public THE ORGANIZATION ENGAGED DAC BOND AS ITS INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. AS SUCH COPIES OF THE AUDITED AND QUARTERLY UNAUDITED FINANCIAL STATEMENTS, AND BOND OFFERING STATEMENTS FOR ALL DEBT ISSUES CAN BE ACCESSED AT ITS WEBSITE, WWW.DACBOND.COM. COPIES OF THE ORGANIZATION'S GROUP 990 AND THE AUDITED FINANCIAL STATEMENTS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES CAN ALSO BE FOUND AT DAC BONDS. THE CONFLICT-OF-INTEREST POLICY IS ALSO AVAILABLE TO THE PUBLIC UPON REQUEST AND/OR CAN BE FOUND AT THE INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT ACCESSIBLE TO THE PUBLIC. Form 990, Part VIII, Line 11d Other Miscellaneous Revenue GIFT SHOP INCOME - Total Revenue: 1594000, Related or Exempt Function Revenue: , Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: 1594000; All Other - Total Revenue: 16607673, Related or Exempt Function Revenue: , Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: 16607673; Form 990, Part XI, Line 9 Other changes in net assets or fund balances OTHER NON-OPERATING EXPENSES - XXX-XX-XXXX; CHANGE IN POSTRETIREMENT REVENUE - -36718000; Schedule F, Part IV Method of accounting ALL OF THE VALUES LISTED ARE AT COST, WITH THE EXCEPTION OF THE INVESTMENTS, WHICH ARE VALUED AT FAIR MARKET VALUE. AFFILIATED ORGANIZATIONS FINANCIAL STATEMENTS THE FINANCIAL STATEMENTS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE AUDITED BY AN INDEPENDENT ACCOUNTING FIRM ON A COMBINED BASIS. THE COMBINED STATEMENTS INCLUDE THE ACCOUNTS OF THE FOLLOWING TAX EXEMPT, SECTION 501(C)(3), INCORPORATED AFFILIATES: MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 13-1924236), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (EIN 13-1624082), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (EIN 13-1624182), S.K.I. REALTY, INC. (EIN 13-3389586), LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES (EIN 20-2212588), AND MSK INSURANCE US, INC.(MVI) EIN 83-0363317. INCLUDED IN THE GROUP EXEMPTION IS MSKCC PROPERTIES LLC (EIN 35-2464610) WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER, AND MSKCC PROTON, INC. (EIN 35-2397819). MEMORIAL SLOAN-KETTERING CANCER CENTER's FINANCIAL STATEMENTS ARE NOTAUDITED INDEPENDENT OF THE COMBINED. REFER TO SCHEDULE D FOR A RECONCILIATION OF THE 990 TO THE CENTER'S FINANCIAL STATEMENTS. PROSTATE CANCER CLINICAL TRIAL 1275 YORK AVE NEW YORK NY 10065 352506225 CANCER CARE DE 239752 22297784 MSKCC MSK ABC LLC 1275 YORK AVE NEW YORK NY 100656007 320752089 MSK Event Services NY 0 0 MSKCC MEMORIAL MEDICAL CARE PC 1275 YORK AVENUE NEW YORK NY 10065 352491455 CANCER CARE NY 501(c)(3) 10 MSKCC true TRI-INSTITUTIONAL THERAPEUTIS DISCOVERY 1300 YORK AVENUE NEW YOYR NY 10065 463673346 MEDICAL RESEARCH EDUCATION DE 501(c)(3) Type I NA false MSKCC REGIONAL NETWORK 1275 YORK AVE NEW YORK NY 10065 200594889 HEALTH CARE NY MEM Related 13178586 false true 1 MEMORIAL RADIATION ONCOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133237927 HEALTH CARE NY MEM Related 49043708 false true 1.00 MEMORIAL DEVELOPMENTAL CHEMO GROUP 1275 YORK AVE NEW YORK NY 10065 133278548 HEALTH CARE NY MEM Related 6178380 false true 1 MEMORIAL MEDICAL CONSULTATION GROUP 1275 YORK AVE NEW YORK NY 10065 133278550 HEALTH CARE NY MEM Related 11194995 false true 1 MEMORIAL CARDIOPULMONARY GROUP 1275 YORK AVE NEW YORK NY 10065 133278552 HEALTH CARE NY MEM Related 6763548 false true 1 MEMORIAL CLINICAL PHYSIOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133278556 HEALTH CARE NY MEM Related 2128419 false true 1 MEMORIAL GASTROENTEROLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133278574 HEALTH CARE NY MEM Related 11850057 false true 1 MEMORIAL HEMATOLOGYLYMPHOMA GROUP 1275 YORK AVE NEW YORK NY 10065 133278575 HEALTH CARE NY MEM Related 25830818 false true 1 MEMORIAL SOLID TUMOR GROUP 1275 YORK AVE NEW YORK NY 10065 133278578 HEALTH CARE NY MEM Related 50183466 false true 1 MEMORIAL NUCLEAR MEDICINE GROUP 1275 YORK AVE NEW YORK NY 10065 133278580 HEALTH CARE NY MEM Related 10548704 false true 1 MEMORIAL DERMATOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133278581 HEALTH CARE NY MEM Related 9205807 false true 1 MEMORIAL INFECTIOUS DISEASE GROUP 1275 YORK AVE NEW YORK NY 10065 133278582 HEALTH CARE NY MEM Related 3222314 false true 1 MEMORIAL ENDOCRINE GROUP 1275 YORK AVE NEW YORK NY 10065 133278583 HEALTH CARE NY MEM Related 5267417 false true 1 MEMORIAL PULMONARY FUNCTION GROUP 1275 YORK AVE NEW YORK NY 10065 133304834 HEALTH CARE NY MEM Related 5324252 false true 1 MEMORIAL PEDIATRICS GROUP 1275 YORK AVE NEW YORK NY 10065 133346908 HEALTH CARE NY MEM Related 10982058 false true 1 MEMORIAL PATHOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133365998 HEALTH CARE NY MEM Related 58649582 false true 1 MEMORIAL ANESTHESIOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133367135 HEALTH CARE NY MEM Related 68171831 false true 1 MSKCC RADIOLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133375559 HEALTH CARE NY MEM Related 96011282 false true 1 MEMORIAL NEUROLOGY GROUP 1275 YORK AVE NEW YORK NY 10065 133399377 HEALTH CARE NY MEM Related 15689212 false true 1 MEMORIAL PSYCHIATRY GROUP 1275 YORK AVE NEW YORK NY 10065 133430629 HEALTH CARE NY MEM Related 5692461 false true 1 MSKCC SURGERY GROUP 1275 YORK AVE NEW YORK NY 10065 134010372 HEALTH CARE NY MEM Related 194327254 false true 1 MEMORIAL SLOAN-KETTERING CANCER CENTER SUFFOLK AT HAUPPAUGE 1275 YORK AVE NEW YORK NY 10065 134059247 HEALTH CARE NY MEM Related 5951539 false true 1 MSK HARRISON 1275 YORK AVE NEW YORK NY 10065 300831483 HEALTH CARE NY MEM Related 17557107 false true 1 MSK MONMOUTH 1275 YORK AVE NEW YORK NY 10065 300937486 HEALTH CARE NY MEM Related 31489174 false true 1 MSK SURGERY NJ 1275 YORK AVE NEW YORK NY 10065 301138432 HEALTH CARE NY MEM Related 235323 false true 1 MSKCC CLINICAL PRACTICE PLAN 1275 YORK AVE NEW YORK NY 10065 510616510 HEALTH CARE NY MEM Related 13858368 false true 1 MSKCC INTEGRATIVE MEDICINE GROUP 1275 YORK AVE NEW YORK NY 10065 542092060 HEALTH CARE NY MEM Related 2301652 false true 1 MEMORIAL SLOAN-KETTERING CANCER CENTER AT BASKING RIDGE NEW JERSEY 1275 YORK AVE NEW YORK NY 10065 593801080 HEALTH CARE NY MEM Related 23973402 false true 1 MSK BERGEN 1275 YORK AVE NEW YORK NY 10065 611791803 HEALTH CARE NY MEM Related 24012636 false true 1 MSK NASSAU 1275 YORK AVE NEW YORK NY 10065 611904151 HEALTH CARE NY MEM Related 10298990 false true 1 MEMORIAL URGENT CARE GROUP 1275 YORK AVE NEW YORK NY 10065 651263291 HEALTH CARE NY MEM Related 8215420 false true 1 MEMORIAL CLINICAL GENETICS GROUP 1275 YORK AVE NEW YORK NY 10065 651263292 HEALTH CARE NY MEM Related 1134069 false true 1 BTS LIQUIDATING LLC 1430 BROADWAY NEW YORK NY 10018 262602952 INVESTMENTS NY MSK Excluded -28286 100138 false false 0.8 CHARITABLE REMAINDER TRUSTS (158) CHARITABLE REMAINDER TRUSTS NY NA Trust false TWO SIGMA US ALL CAP 89 NEXUS WAY CAMANA BAY GRAND CAYMAN CJ KY19007 INVESTMENT CJ MSK C Corporation 27624342 118140305 1.0000 true AXAR OFFSHORE FUND LT PO BOX 309 UGLAND HOUSE GRAND CAYMAN CJ KY11104 INVESTMENT CJ MSK C Corporation 1008741 49326155 0.8035 true false false false false false false false false false false true true true false false false false false false MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE L 997179000 COST SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH L 256149000 COST SKIREALTY INC L 6455000 COST LOUIS V GERSTNER JR GRADUATE SCHOOL L 80000 COST MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE M 8495000 COST SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH M 8153000 COST SKI REALTY INC K 5556000 COST MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 100656007 131924236 X 0 543822 543822 1507188891 1507732713 1000000 250000 0 0 0 MEMORIAL SLOAN KETTERING CANCER CENTER 1275 York Avenue New York NY 10065 912154267 0 0 0 0 0 0 0 0 0 0